Andrew Bentall MD MBChB
Chronic Renal Failure & Dialysis, Glomerular Disease, Kidney & Pancreas Transplantation
Assistant Professor Nephrology and Transplant Medicine
Join to View Full Profile
200 1st St SWRochester, MN 55905
Phone+1 507-284-2511
Dr. Bentall is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Andrew Bentall is a nephrologist in Rochester, MN and is affiliated with Mayo Clinic Hospital - Rochester. He received his medical degree from Birmingham, UK and has been in practice 13 years. He specializes in glomerular disease and kidney & pancreas transplantation.
Education & Training
Birmingham University Medical SchoolClass of 2004
Certifications & Licensure
WI State Medical License 2021 - 2027
MN State Medical License 2017 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Nephrology
Publications & Presentations
PubMed
- Early Removal of Ureteral Stents When Attached to the Foley Catheter in Living Donor Kidney Transplant Recipients Reduces Urinary Tract Infections.Jenny Lam, Ibrahim Elali, Mohammed Mahgoub, Esma Kesik, Byron Smith
Clinical Transplantation. 2025-10-01 - Treatment With mTOR Inhibitors as Primary Immunosuppression After Combined Heart and Kidney Transplantation.Hilmi Alnsasra, Rabea Asleh, Fouad Khalil, Elias Akiki, Alexandros Briasoulis
Journal of Cardiac Failure. 2025-09-01 - The New Horizon: A Viewpoint of Novel Drugs, Biomarkers, Artificial Intelligence, and Self-Management in Improving Kidney Transplant Outcomes.Artur Quintiliano, Andrew J Bentall
Journal of Clinical Medicine. 2025-07-17
Journal Articles
- Long‐Term Outcomes of Eculizumab‐Treated Positive Crossmatch Recipients: Allograft Survival, Histologic Findings, and Natural History of the Donor‐Specific AntibodiesMatthew Everly, Lynn D Cornell, Carrie A Schinstock, Andrew J Bentall, Mark D Stegall, American journal of transplantation
Press Mentions
Kidney Transplant Patients Could Live Drug-Free Thanks to New Stem Cell TherapyAugust 11th, 2025- MDR-101 May End Post-Kidney Transplant Immunosuppression NeedJuly 8th, 2025
- Eliminating the Need for Lifelong Immunosuppressive Medications for Transplant PatientsJuly 7th, 2025
- Join now to see all
Professional Memberships
- Member
- American Society of TransplantationMember
- British Transplant SocietyMember
- International Society of NephrologyMember
- The Transplantation SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
